Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample

BACKGROUND: We sought to determine whether clinical response or tolerance to the Selective Serotonin Reuptake Inhibitor (SSRI) citalopram is associated with genetic polymorphisms in potentially relevant pharmacokinetic enzymes. METHODOLOGY: We used a two-stage case-control study design in which we s...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Eric J., Slager, Susan L., Kraft, Jeffrey B., Jenkins, Greg D., Reinalda, Megan S., McGrath, Patrick J., Hamilton, Steven P.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268970/
https://www.ncbi.nlm.nih.gov/pubmed/18382661
http://dx.doi.org/10.1371/journal.pone.0001872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268970/
https://www.ncbi.nlm.nih.gov/pubmed/18382661
http://dx.doi.org/10.1371/journal.pone.0001872

Ejemplares similares